Nilsine Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207K Sell
938
-141
-13% -$39K 0.01% 415
2026
Q1
$304K Buy
1,079
+90
+9% +$26.7K 0.02% 333
2025
Q4
$270K Buy
+989
New +$269K 0.02% 343

Other funds holding CME

Nilsine Partners's CME Position: Q2 2026 in Review

Nilsine Partners reduced its CME Group (CME) stake by 13% in Q2 2026, selling an estimated $39K and leaving 938 shares worth $207K. The position accounts for 0.01% of the portfolio, ranked #415.

Nilsine Partners first reported a position in CME in Q4 2025 and has held it in 3 quarters since. The position peaked at $304K in Q1 2026. 439 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Nilsine Partners held 938 shares of CME Group worth $207K as of Q2 2026.
  • Nilsine Partners sold 141 CME Group shares in Q2 2026, an estimated $39K.
  • CME Group made up 0.01% of Nilsine Partners's portfolio in Q2 2026, its #415 holding.
  • Nilsine Partners first reported a position in CME Group in Q4 2025 and has held it in 3 quarters since.
  • Nilsine Partners's CME Group position peaked at $304K in Q1 2026.
  • 439 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.